Minoryx Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Minoryx Therapeutics's estimated annual revenue is currently $6.4M per year.
- Minoryx Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Minoryx Therapeutics has 41 Employees.
- Minoryx Therapeutics grew their employee count by 8% last year.
Minoryx Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Medical Officer | Reveal Email/Phone |
Minoryx Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Minoryx Therapeutics?
Minoryx is a clinical stage biotech company focusing on the development of novel therapies for orphan CNS diseases with high unmet medical needs. The company's lead program, leriglitazone (MIN-102), a novel, selective PPARγ agonist, is currently being evaluated in X-ALD and Friedreich's Ataxia. The company is backed by a syndicate of experienced investors and has support from a network of other organizations. Minoryx was founded in 2011, has operations in Spain and Belgium and has raised a total of €50M through Series A & B financing rounds.
keywords:N/AN/A
Total Funding
41
Number of Employees
$6.4M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Minoryx Therapeutics News
List of Key Players Covered in the Report: Applied Genetic Technologies Corporation, MedDay SA, Bluebird bio, Inc., Minoryx Therapeutics S.L...
... have their X linked Adrenoleukodystrophy drug candidates in the most advanced stage, i.e. phase II/ III include, Minoryx Therapeutics.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $22.1M | 88 | 33% | N/A |
#2 | $30.5M | 113 | -6% | N/A |